High-throughput system can regulate gene expression for treating sickle cell disease, beta thalassemia

By | May 7, 2021
St. Jude Children’s Research Hospital scientists have developed an integrated, high-throughput system to better understand and possibly manipulate gene expression for treatment of disorders such as sickle cell disease and beta thalassemia. The research appears today in the journal Nature Genetics.